Brief: Perspective Therapeutics Look Forward To Provide Safety And Efficacy Updates In 2H 2024
17/01/2024 13:26
Jan 17 (Reuters) - Perspective Therapeutics Inc
CATX.A :
* PERSPECTIVE COMMENCES RECRUITMENT FOR SECOND DOSE
ESCALATION
COHORTS IN CLINICAL STUDIES OF TWO LEAD PROGRAMS:
(212)PB VMT-Α-NET AND (212)PB VMT01
* PERSPECTIVE THERAPEUTICS INC - LOOK FORWARD TO PROVIDING
FURTHER
SAFETY AND EFFICACY UPDATES IN SECOND HALF OF 2024
Source text for Eikon: ID:nGNX9tB7vr
Further company coverage: CATX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Perspective Therapeutics
See all newsPerspective Therapeutics Q2 net loss widens on higher R&D costs
Brief: Perspective Therapeutics Q2 EPS USD -0.22
Brief: Perspective Therapeutics Expands Therapeutic Focus Areas First Patient Dosed With Vmt-Α-Net In The Meningioma Cohort Of A Phase 1/2A Study
Brief: Perspective Therapeutics Q1 EPS USD -0.25
Perspective Therapeutics rises as experimental cancer drug shows promise